首頁 > 市場調查報告書 > 製藥

全球鹽酸羥考酮市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1346810

全球鹽酸羥考酮市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Oxycodone Hydrochloride Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 231 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球鹽酸羥考酮市場需求預計將從 2022 年的 406.23 萬美元達到 2030 年近 612.65 萬美元的市場規模，2023-2030 年研究期間年複合成長率為 5.27%。

鹽酸羥考酮是一種強效鴉片類鎮痛藥物，用於治療中度至重度疼痛。它屬於鴉片類激動劑藥物類別。它有多種配方，包括立即釋放和緩釋版本，可在不同時間段提供疼痛緩解。

市場動態：

鹽酸羥考酮市場的成長受到多種因素的影響。這主要是由於中度至重度疼痛（例如醫療程序、手術、外傷、損傷和癌症相關疼痛後）對有效疼痛管理的需求不斷增加而推動的。全球人口老齡化和慢性疼痛的流行導致需求不斷成長。醫療專業人員的處方實踐、醫療保健基礎設施以及對疼痛管理方案的認知都會影響其利用率。監管框架、製藥行業動態和鴉片類藥物處方指南也發揮著作用。必須在不斷努力平衡疼痛緩解需求與相關風險和挑戰的背景下理解市場的演變。通過可靠的醫療來源了解情況對於了解鹽酸羥考酮市場的現狀至關重要。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球鹽酸羥考酮市場的每個細分市場進行了包容性評估。鹽酸羥考酮行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區鹽酸羥考酮市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。鹽酸羥考酮市場的主要參與者包括禮來公司、吉利德科學公司、Manus Aktteva Biopharma LLP、Arevipharma、Saneca Pharma、Cipla Ltd、Noramco、Macfarian Smith、Teva Pharmaceutical Industries Ltd、Taj Pharma、Chattem Chemicals Inc.。、Mayne Pharma Group Limited、Dr. Reddy's Laboratories Ltd、Siegfried、Rhodes Pharmaceuticals、Mallinckrodt Plc、Johnson & Johnson、Bristol-Myers Squibb Company、Sun Pharmaceutical Industries Ltd、Lupin Ltd 和Sanofi Sais。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史和預測數據銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史和預測數據銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：鹽酸羥考酮公司的競爭格局

鹽酸羥考酮市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Eli Lilly and Co.

公司簡介
公司收入
產品
最近的發展

Gilead Sciences Inc.

公司簡介
公司收入
產品
最近的發展

Manus Aktteva Biopharma LLP

公司簡介
公司收入
產品
最近的發展

Arevipharma

公司簡介
公司收入
產品
最近的發展

Saneca Pharma

公司簡介
公司收入
產品
最近的發展

Cipla Ltd

公司簡介
公司收入
產品
最近的發展

Noramco

公司簡介
公司收入
產品
最近的發展

Macfarian Smith

公司簡介
公司收入
產品
最近的發展

Teva Pharmaceutical Industries Ltd

公司簡介
公司收入
產品
最近的發展

Taj Pharma

公司簡介
公司收入
產品
最近的發展

Chattem Chemicals Inc.

公司簡介
公司收入
產品
最近的發展

Mayne Pharma Group Limited

公司簡介
公司收入
產品
最近的發展

Dr. Reddy's Laboratories Ltd

公司簡介
公司收入
產品
最近的發展

Siegfried

公司簡介
公司收入
產品
最近的發展

Rhodes Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

Mallinckrodt Plc

公司簡介
公司收入
產品
最近的發展

Johnson & Johnson

公司簡介
公司收入
產品
最近的發展

Bristol-Myers Squibb Company

公司簡介
公司收入
產品
最近的發展

Sun Pharmaceutical Industries Ltd

公司簡介
公司收入
產品
最近的發展

Lupin Ltd

公司簡介
公司收入
產品
最近的發展

Sanofi Sais

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112072

The global demand for Oxycodone Hydrochloride Market is presumed to reach the market size of nearly USD 612.65 MN by 2030 from USD 406.23 MN in 2022 with a CAGR of 5.27% under the study period 2023 - 2030.

Oxycodone hydrochloride is a powerful opioid analgesic medication used to manage moderate to severe pain. It belongs to the class of medications known as opioid agonists. It is available in various formulations, including immediate-release and extended-release versions, to provide pain relief over different time periods.

MARKET DYNAMICS:

The growth of the oxycodone hydrochloride market is influenced by several factors. It is primarily driven by the increasing need for effective pain management in cases of moderate to severe pain, such as after medical procedures, surgeries, trauma, injury, and cancer-related pain. The aging global population and the prevalence of chronic pain conditions contribute to the rising demand. Medical professionals' prescription practices, healthcare infrastructure, and awareness about pain management options impact its utilization. Regulatory frameworks, pharmaceutical industry dynamics, and guidelines for opioid prescription also play a role. The market's evolution must be understood in the context of the ongoing efforts to balance pain relief needs with the associated risks and challenges. Staying informed through reliable medical sources is essential for understanding the current state of the oxycodone hydrochloride market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oxycodone hydrochloride. The growth and trends of oxycodone hydrochloride industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oxycodone hydrochloride market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Controlled-Release
Immediate-Release

By Route Of Administration

Oral
Parenteral

By Distribution Channel

Hospitals
Retail Pharmacies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oxycodone Hydrochloride market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oxycodone Hydrochloride market include Eli Lilly and Co., Gilead Sciences Inc., Manus Aktteva Biopharma LLP, Arevipharma, Saneca Pharma, Cipla Ltd, Noramco, Macfarian Smith, Teva Pharmaceutical Industries Ltd, Taj Pharma, Chattem Chemicals Inc., Mayne Pharma Group Limited, Dr. Reddy's Laboratories Ltd, Siegfried, Rhodes Pharmaceuticals, Mallinckrodt Plc, Johnson & Johnson, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd, Lupin Ltd, and Sanofi Sais. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . OXYCODONE HYDROCHLORIDE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Controlled-Release Historic and Forecast Sales by Regions
5.5 Immediate-Release Historic and Forecast Sales by Regions

6 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route of Administration
6.4 Oral Historic and Forecast Sales by Regions
6.5 Parenteral Historic and Forecast Sales by Regions

7 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1 Overview by Distribution Channel
7.2 Historical and Forecast Data
7.3 Analysis by Distribution Channel
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Retail Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OXYCODONE HYDROCHLORIDE COMPANIES

9.1. Oxycodone Hydrochloride Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF OXYCODONE HYDROCHLORIDE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Eli Lilly and Co.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Gilead Sciences Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Manus Aktteva Biopharma LLP
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Arevipharma
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Saneca Pharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Cipla Ltd
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Noramco
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Macfarian Smith
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Teva Pharmaceutical Industries Ltd
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Taj Pharma
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Chattem Chemicals Inc.
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Mayne Pharma Group Limited
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Dr. Reddy's Laboratories Ltd
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Siegfried
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Rhodes Pharmaceuticals
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. Mallinckrodt Plc
- 10.18.1. Company Overview
- 10.18.2. Company Revenue
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. Johnson & Johnson
- 10.19.1. Company Overview
- 10.19.2. Company Revenue
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. Bristol-Myers Squibb Company
- 10.20.1. Company Overview
- 10.20.2. Company Revenue
- 10.20.3. Products
- 10.20.4. Recent Developments
10.21. Sun Pharmaceutical Industries Ltd
- 10.21.1. Company Overview
- 10.21.2. Company Revenue
- 10.21.3. Products
- 10.21.4. Recent Developments
10.22. Lupin Ltd
- 10.22.1. Company Overview
- 10.22.2. Company Revenue
- 10.22.3. Products
- 10.22.4. Recent Developments
10.23. Sanofi Sais
- 10.23.1. Company Overview
- 10.23.2. Company Revenue
- 10.23.3. Products
- 10.23.4. Recent Developments